Biblio

Export 142 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
S. Petersen, Houston, S., Qin, H., Tague, C., and Studley, J., “The Utilization of Robotic Pets in Dementia Care.”, J Alzheimers Dis, vol. 55, no. 2, pp. 569-574, 2017.
M. Petersen, Hall, J., Parsons, T., Johnson, L., and O'Bryant, S., “Combining Select Blood-Based Biomarkers with Neuropsychological Assessment to Detect Mild Cognitive Impairment among Mexican Americans.”, J Alzheimers Dis, vol. 75, no. 3, pp. 739-750, 2020.
M. E. Petersen, Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., Schupf, N., Krinsky-McHale, S. J., Mapstone, M., Silverman, W., Lott, I., Klunk, W., Head, E., Christian, B., Foroud, T., Lai, F., H Rosas, D., Zaman, S., Wang, M. - C., Tycko, B., Lee, J., Handen, B., Hartley, S., Fortea, J., and O'Bryant, S., “Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.”, J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
J. R. Petrella, Michael, A. M., Qian, M., Nwosu, A., Sneed, J., Goldberg, T. E., Devanand, D. P., and P Doraiswamy, M., “Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 483-494, 2023.
I. H. Philippens, Ormel, P. R., Baarends, G., Johansson, M., Remarque, E. J., and Doverskog, M., “Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 101-113, 2017.
A. Ka Sin Phua, Hiu, S. Kuan Wei, Goh, W. King, Ikram, M. Kamran, Venketasubramanian, N., Tan, B. Yeow, Chen, C. Li- Hsian, and Xu, X., “Low Accuracy of Brief Cognitive Tests in Tracking Longitudinal Cognitive Decline in an Asian Elderly Cohort.”, J Alzheimers Dis, vol. 62, no. 1, pp. 409-416, 2018.
I. Piaceri, Bessi, V., Matà, S., Polito, C., Tedde, A., Berti, V., Bagnoli, S., Braccia, A., Del Mastio, M., Pignone, A. Moggi, Pupi, A., Sorbi, S., and Nacmias, B., “Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 1, pp. 41-46, 2018.
I. Piaceri, Imperiale, D., Ghidoni, E., Atzori, C., Bagnoli, S., Ferrari, C., Ungari, S., Ambrogio, L., Sorbi, S., and Nacmias, B., “Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1683-1689, 2018.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., “Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.”, Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
F. Piazza and Winblad, B., “Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?”, J Alzheimers Dis, vol. 52, no. 2, pp. 417-20, 2016.
R. Piccarducci, Caselli, M. Chiara, Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., and Martini, C., “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
E. K. Pickett, Koffie, R. M., Wegmann, S., Henstridge, C. M., Herrmann, A. G., Colom-Cadena, M., Lleo, A., Kay, K. R., Vaught, M., Soberman, R., Walsh, D. M., Hyman, B. T., and Spires-Jones, T. L., “Non-Fibrillar Oligomeric Amyloid-β within Synapses.”, J Alzheimers Dis, vol. 53, no. 3, pp. 787-800, 2016.
N. Pierrot, Lhommel, R., Quenon, L., Hanseeuw, B., Dricot, L., Sindic, C., Maloteaux, J. - M., Octavea, J. - N., and Ivanoiu, A., “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
R. J. Piers, Liu, Y., Ang, T. F. A., Tao, Q., Au, R., and Qiu, W. Qiao, “Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1269-1279, 2021.
R. J. Piers, Devlin, K. N., Ning, B., Liu, Y., Wasserman, B., Massaro, J. M., Lamar, M., Price, C. C., Swenson, R., Davis, R., Penney, D. L., Au, R., and Libon, D. J., “Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1611-1620, 2017.
M. Pietto, Parra, M. A., Trujillo, N., Flores, F., García, A. M., Bustin, J., Richly, P., Manes, F., Lopera, F., Ibáñez, A., and Baez, S., “Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1325-40, 2016.
M. Pievani, Pini, L., Ferrari, C., Pizzini, F. B., Galazzo, I. Boscolo, Cobelli, C., Cotelli, M., Manenti, R., and Frisoni, G. B., “Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Networks.”, J Alzheimers Dis, vol. 57, no. 3, pp. 825-843, 2017.
K. E. Pike, Zeneli, A., Ong, B., Price, S., and Kinsella, G. J., “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
J. A. Pillai, Lei, K., Bena, J., Penn, L., and Leverenz, J. B., “Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOEɛ4 Status.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1493-1504, 2021.
J. A. Pillai, Appleby, B. S., Safar, J., and Leverenz, J. B., “Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts.”, J Alzheimers Dis, vol. 64, no. 3, pp. 973-980, 2018.
J. A. Pillai, Bonner-Jackson, A., Bekris, L. M., Safar, J., Bena, J., and Leverenz, J. B., “Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1051-1058, 2019.
A. Pilotto, Imarisio, A., Carrarini, C., Russo, M., Masciocchi, S., Gipponi, S., Cottini, E., Aarsland, D., Zetterberg, H., Ashton, N. J., Hye, A., Bonanni, L., and Padovani, A., “Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 82, no. 3, pp. 913-919, 2021.
A. Pilotto, Turrone, R., Liepelt-Scarfone, I., Bianchi, M., Poli, L., Borroni, B., Alberici, A., Premi, E., Formenti, A., Bigni, B., Cosseddu, M., Cottini, E., Berg, D., and Padovani, A., “Vascular Risk Factors and Cognition in Parkinson's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 563-70, 2016.
L. S. Pimentel, Allard, S., Carmo, S. Do, Weinreb, O., Danik, M., Hanzel, C. E., Youdim, M. B., and A Cuello, C., “The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 2, pp. 373-83, 2015.
C. Pimouguet, Le Goff, M., Wittwer, J., Dartigues, J. - F., and Helmer, C., “Benefits of Occupational Therapy in Dementia Patients: Findings from a Real-World Observational Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 509-517, 2017.

Pages